<DOC>
	<DOC>NCT00888186</DOC>
	<brief_summary>The purpose of this study is to study different kinds of dyskinesias in advanced Parkinson's disease appearing at different levels of levodopa infusion dose. The hypothesis is that different dyskinesias (dystonia, chorea) correlate to different levels of levodopa concentrations, as detected in plasma.</brief_summary>
	<brief_title>Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics</brief_title>
	<detailed_description>By using duodenal infusion of levodopa/carbidopa, the plasma concentration of levodopa can be kept fairly constant. Different doses, 10-20% higher or lower than the individually optimized dose will be used. Motor performance is captured by video recordings to be compared to/correlated with plasma levodopa concentrations.</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Carbidopa, levodopa drug combination</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Clinical diagnosis of idiopathic Parkinson's disease Ongoing treatment with Duodopa Occurrence of dyskinesias, difficult to manage Age 3090 years Hoehn &amp; Yahr stage 35 at worst Treatment with dopamine agonist or glutamate antagonist Dementia Psychosis Treatment with typical neuroleptics</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Dyskinesias</keyword>
	<keyword>Duodenal levodopa infusion</keyword>
	<keyword>Dose optimization</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>